TIDMFIPP
Frontier IP Group plc
06 December 2022
Reach - a non-regulatory announcement
AIM: FIPP
06 December 2022
Frontier IP Group Plc
("Frontier IP" or the "Group")
Portfolio news - Frontier IP to host Portfolio Demo Day at the
Imperial War Museum, Duxford Cambridge
Frontier IP, a specialist in commercialising intellectual
property, is holding a Portfolio Demo Day at the Imperial War
Museum, Duxford, Cambridge ("IWM Duxford" or the "Museum") on the
afternoon and evening of Tuesday 6(th) December 2022.
The event is an opportunity for some of Frontier IP's portfolio
companies to present, demonstrate and discuss their new
technologies to help tackle fundamental challenges, such as
climate, energy, food, water and health.
Guests include investors, representatives of companies supported
by Frontier IP, and industry partners. An afternoon session in the
Museum's Marshall Auditorium will consist of presentations from
portfolio companies, while the evening reception will give them the
opportunity to showcase their technology. No new material
information will be disclosed.
The portfolio companies presenting and demonstrating
technologies are:
-- Cambridge Raman Imaging is using graphene-based ultra-fast
lasers and artificial intelligence in next generation Raman-imaging
microscopes to research, diagnose and monitor diseases, such as
cancers
-- CamGraPhIC is developing graphene-based photonics with the
potential to make data and telecommunications transmission much
faster while using less energy
-- Elute is showcasing its use of forensic linguistic algorithms
for high-speed search and comparison of unstructured document
datasets
-- Celerum is demonstrating its novel artificial intelligence
based on meta-heuristics, including nature-inspired computing, to
make logistics more efficient, supporting efforts to improve the
industry's carbon efficiency
-- Nandi Proteins is discussing its customised ingredients based
on vegetable and animal proteins. These can be used to replace
undesirable ingredients such as fat, gluten and E-number additives
in processed foods, or those that people do not want to consume -
for example replacing animal proteins with vegetable proteins
-- The Vaccine Group is developing novel herpesvirus-based
vaccine platforms. Projects include those to tackle Lassa fever,
African Swine Fever, Streptococcus suis and Porcine Reproductive
and Respiratory Syndrome in animals, and COVID-19 in humans
-- Pulsiv will be showing its patented technology to
significantly improve the energy efficiency of power supplies,
battery chargers, and LED lighting. It also extracts much more
energy from photovoltaic solar cells, improving their output
-- Alusid is creating premium-quality tiles and architectural surfaces from industrial waste.
-- Des Solutio is developing safer and greener alternatives to
the chemicals currently used to make beauty, pharmaceutical,
personal healthcare and other products
-- InSignals Neurotech is showing its patented technology to aid
deep brain surgery on patients suffering neurological diseases,
such as Parkinson's disease
-- AquaInSilico is presenting its sophisticated software tools
to optimise wastewater treatment, with potential applications
spanning many different industries. It is a UN Ocean Innovator,
working on a project to help protect and conserve one of the
world's most diverse marine environments around the Cape Verde
archipelago
-- Liquid Graphene is a new spin-out company looking to exploit
graphene-based inks to reduce the cost of solar cell manufacture
and use
Frontier IP Chief Executive Officer Neil Crabb said: "We are
looking forward to demonstrating the exciting technologies being
developed by our portfolio companies and the role they have to play
in helping to meet some of the serious challenges posed by climate
change, water, food and energy."
ENQUIRIES
Frontier IP Group Plc T: 020 7332 2338
Neil Crabb, Chief Executive Officer neil@frontierip.co.uk
Andrew Johnson, Communications and investor M: 07464 546 025
relations
andrew.johnson@frontierip.co.uk
Company website: www.frontierip.co.uk
Allenby Capital Limited (Nominated Adviser) T: 0203 328 5656
Nick Athanas / George Payne
ABOUT FRONTIER IP
Frontier IP unites science and commerce by identifying strong
intellectual property and accelerating its development through a
range of commercialisation services. A critical part of the Group's
work is involving relevant industry partners at an early stage of
development to ensure technology meets real world demands and
needs.
The Group looks to build and grow a portfolio of equity stakes
and licence income by taking an active involvement in spin-out
companies, including support for fund raising and collaboration
with relevant industry partners at an early stage of
development.
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAVELFBLLLXFBB
(END) Dow Jones Newswires
December 06, 2022 02:00 ET (07:00 GMT)
Frontier Ip (LSE:FIPP)
Historical Stock Chart
From Apr 2024 to May 2024
Frontier Ip (LSE:FIPP)
Historical Stock Chart
From May 2023 to May 2024